Your browser doesn't support javascript.
loading
Regulated Expansion and Survival of Chimeric Antigen Receptor-Modified T Cells Using Small Molecule-Dependent Inducible MyD88/CD40.
Foster, Aaron E; Mahendravada, Aruna; Shinners, Nicholas P; Chang, Wei-Chun; Crisostomo, Jeannette; Lu, An; Khalil, Mariam; Morschl, Eva; Shaw, Joanne L; Saha, Sunandan; Duong, MyLinh T; Collinson-Pautz, Matthew R; Torres, David L; Rodriguez, Tania; Pentcheva-Hoang, Tsvetelina; Bayle, J Henri; Slawin, Kevin M; Spencer, David M.
Afiliação
  • Foster AE; Bellicum Pharmaceuticals, Houston, TX 77030, USA. Electronic address: afoster@bellicum.com.
  • Mahendravada A; Bellicum Pharmaceuticals, Houston, TX 77030, USA.
  • Shinners NP; Bellicum Pharmaceuticals, Houston, TX 77030, USA.
  • Chang WC; Bellicum Pharmaceuticals, Houston, TX 77030, USA.
  • Crisostomo J; Bellicum Pharmaceuticals, Houston, TX 77030, USA.
  • Lu A; Bellicum Pharmaceuticals, Houston, TX 77030, USA.
  • Khalil M; Bellicum Pharmaceuticals, Houston, TX 77030, USA.
  • Morschl E; Bellicum Pharmaceuticals, Houston, TX 77030, USA.
  • Shaw JL; Bellicum Pharmaceuticals, Houston, TX 77030, USA.
  • Saha S; Bellicum Pharmaceuticals, Houston, TX 77030, USA.
  • Duong MT; Bellicum Pharmaceuticals, Houston, TX 77030, USA.
  • Collinson-Pautz MR; Bellicum Pharmaceuticals, Houston, TX 77030, USA.
  • Torres DL; Bellicum Pharmaceuticals, Houston, TX 77030, USA.
  • Rodriguez T; Bellicum Pharmaceuticals, Houston, TX 77030, USA.
  • Pentcheva-Hoang T; Bellicum Pharmaceuticals, Houston, TX 77030, USA.
  • Bayle JH; Bellicum Pharmaceuticals, Houston, TX 77030, USA.
  • Slawin KM; Bellicum Pharmaceuticals, Houston, TX 77030, USA.
  • Spencer DM; Bellicum Pharmaceuticals, Houston, TX 77030, USA. Electronic address: dspencer@bellicum.com.
Mol Ther ; 25(9): 2176-2188, 2017 09 06.
Article em En | MEDLINE | ID: mdl-28697888
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Recombinantes de Fusão / Receptores de Antígenos de Linfócitos T / Linfócitos T / Antígenos CD28 / Antígenos CD40 Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Mol Ther Assunto da revista: BIOLOGIA MOLECULAR / TERAPEUTICA Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Recombinantes de Fusão / Receptores de Antígenos de Linfócitos T / Linfócitos T / Antígenos CD28 / Antígenos CD40 Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Mol Ther Assunto da revista: BIOLOGIA MOLECULAR / TERAPEUTICA Ano de publicação: 2017 Tipo de documento: Article